|
AVAILABLE TESTS |
CLINICAL INDICATIONS |
| IMMUNE STATUS EVALUATION |
|
| Lymphocyte
Subsets |
Used to evaluate
the immune status of individuals and assess disease progression.
Meets CDC guidelines for HIV monitoring. |
| CD4
(T4)/CD 8 (T8) |
Used to monitor
HIV positive individuals, to assess their immune status and determine
necessity for therapy. |
| CD4
(T4) Lymphocytes only |
Used to monitor
HIV positive individuals. |
| CD3
(T3) Analysis and Subsets |
Used to monitor
effectiveness of immunosuppressive therapy in transplant patients. |
| CD3
Analysis Only |
Used to monitor
effectiveness of immunosuppressive therapy in transplant patients. |
| IMMUNOPHENOTYPING |
|
| Leukemia/Lymphoma/Plasma
Cell Panel |
Used to differentiate
reactive from neoplastic lesions, to subclassify lymphoma, and
to define the lineage and developmental stage of hematopoietic
neoplasms. |
| DNA
CELL CYCLE ANALYSIS |
|
| DNA
Cell Cycle Analysis |
Used to predict
ploidy and proliferative activity of certain solid tumors. The
finding of DNA aneuploid and/or a high S-phase fraction predicts
decreased disease free and overall survival times in many malignancies. |
